Literature DB >> 16775729

[Anesthesia and analgesia in addicts: basis for establishing a standard operating procedure].

J Jage1, F Heid.   

Abstract

Addicts have an exaggerated organic and psychological comorbidity and in cases of major operations or polytrauma they are classified as high-risk patients. Additional perioperative problems are a higher analgetics requirement, craving, physical and/or psychological withdrawal symptoms, hyperalgesia and tolerance. However, the clinical expression depends on the substance abused. For a better understanding of the necessary perioperative measures, it is helpful to classify the substances into central nervous system depressors (e.g. heroin, alcohol, sedatives, hypnotics), stimulants (e.g. cocaine, amphetamines, designer drugs) and other psychotropic substances (e.g. cannabis, hallucinogens, inhalants). The perioperative therapy should not be a therapy for the addiction, as this is senseless. On the contrary, the characteristics of this chronic disease must be accepted. Anesthesia and analgesia must be generously stress protective and sufficiently analgesically effective. Equally important perioperative treatment principles are stabilization of physical dependence by substitution with methadone (for heroin addicts) or benzodiazepines/clonidine (for alcohol, sedatives and hypnotics addiction), avoidance of stress and craving, thorough intraoperative and postoperative stress relief by using regional techniques or systematically higher than normal dosages of anesthetics and opioids, strict avoidance of inadequate dosage of analgetics, postoperative optimization of regional or systemic analgesia by non-opioids and coanalgetics and consideration of the complex physical and psychological characteristics and comorbidities. Even in cases of abstinence (clean) an inadequate dosage must be avoided as this, and not an adequate pain therapy sometimes even with strong opioids, can potentially activate addiction. A protracted abstinence syndrome after withdrawal of opioids can lead to increased response to administered opioids (e.g. analgesia, side-effects).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775729     DOI: 10.1007/s00101-006-1012-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  72 in total

Review 1.  Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy.

Authors:  Jianren Mao
Journal:  Pain       Date:  2002-12       Impact factor: 6.961

2.  Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification.

Authors:  N Loimer; L Linzmayer; J Grünberger
Journal:  Drug Alcohol Depend       Date:  1991-10       Impact factor: 4.492

3.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

Authors:  J T Sullivan; K Sykora; J Schneiderman; C A Naranjo; E M Sellers
Journal:  Br J Addict       Date:  1989-11

4.  Opioid pseudoaddiction--an iatrogenic syndrome.

Authors:  D E Weissman; J D Haddox
Journal:  Pain       Date:  1989-03       Impact factor: 6.961

Review 5.  Opioid tolerance and dependence -- do they matter?

Authors:  Jürgen Jage
Journal:  Eur J Pain       Date:  2005-04       Impact factor: 3.931

Review 6.  Tramadol: a review of its use in perioperative pain.

Authors:  L J Scott; C M Perry
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

7.  Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.

Authors:  M J Millan; B J Morris; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1988-11       Impact factor: 4.030

8.  Co-morbidity of lifetime psychiatric disorder among male alcoholic patients.

Authors:  E C Penick; B J Powell; E J Nickel; S F Bingham; K R Riesenmy; M R Read; J Campbell
Journal:  Alcohol Clin Exp Res       Date:  1994-12       Impact factor: 3.455

9.  Opioid therapy in patients with a history of substance abuse.

Authors:  Steven D Passik; Kenneth L Kirsh
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 10.  Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.

Authors:  J P Gonzalez; R N Brogden
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

View more
  5 in total

1.  [Perioperative pain management: what is evidence based?].

Authors:  D Meisenzahl; J Souquet; P Kessler
Journal:  Orthopade       Date:  2014-12       Impact factor: 1.087

Review 2.  [Perioperative analgesia for opioid tolerant patients].

Authors:  G Lerchl-Wanie; R Angster
Journal:  Anaesthesist       Date:  2010-07       Impact factor: 1.041

Review 3.  [Management of patients with chronic pain in acute and perioperative medicine : An interdisciplinary challenge].

Authors:  J Erlenwein; M Pfingsten; M Hüppe; D Seeger; A Kästner; R Graner; F Petzke
Journal:  Anaesthesist       Date:  2020-02       Impact factor: 1.041

Review 4.  [Patients with pre-existing chronic pain and/or psychological problems].

Authors:  M Schiltenwolf; R Klinger
Journal:  Orthopade       Date:  2008-10       Impact factor: 1.087

Review 5.  [Drugs for postoperative analgesia: routine and new aspects: Part 2: opioids, ketamine and gabapentinoids].

Authors:  J Jage; R Laufenberg-Feldmann; F Heid
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.